Cargando…

Differential In Vivo Tumorigenicity of Distinct Subpopulations from a Luminal-Like Breast Cancer Xenograft

Intratumor heterogeneity caused by genetic, phenotypic or functional differences between cancer cell subpopulations is a considerable clinical challenge. Understanding subpopulation dynamics is therefore central for both optimization of existing therapy and for development of new treatment. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skrbo, Nirma, Hjortland, Geir-Olav, Kristian, Alexandr, Holm, Ruth, Nord, Silje, Prasmickaite, Lina, Engebraaten, Olav, Mælandsmo, Gunhild M., Sørlie, Therese, Andersen, Kristin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242648/ https://www.ncbi.nlm.nih.gov/pubmed/25419568 http://dx.doi.org/10.1371/journal.pone.0113278

Ejemplares similares

Interplay of choline metabolites and genes in patient-derived breast cancer xenografts
por: Grinde, Maria T, et al.
Publicado: (2014)

Aldehyde Dehydrogenase (ALDH) Activity Does Not Select for Cells with Enhanced Aggressive Properties in Malignant Melanoma
por: Prasmickaite, Lina, et al.
Publicado: (2010)

Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models
por: Moestue, Siver A, et al.
Publicado: (2010)

Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma
por: Engesæter, Birgit, et al.
Publicado: (2012)

Breast cancer patient-derived explant cultures recapitulate in vivo drug responses
por: Pettersen, Solveig, et al.
Publicado: (2023)

Liver X receptors induce antiproliferative effects in basal‐like breast cancer
por: Haugen, Mads Haugland, et al.
Publicado: (2023)

Basal‐like breast cancer engages tumor‐supportive macrophages via secreted factors induced by extracellular S100A4
por: Prasmickaite, Lina, et al.
Publicado: (2018)

Detection of phenotype‐specific therapeutic vulnerabilities in breast cells using a CRISPR loss‐of‐function screen
por: Barkovskaya, Anna, et al.
Publicado: (2021)

Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer
por: Moestue, Siver A, et al.
Publicado: (2013)

Establishment and characterization of two breast cancer xenografts in immunodeficient mice for studies on hormone-dependent and hormone-independent tumor growth, progression and invasion
por: Engebraaten, O, et al.
Publicado: (2005)

Biodistribution of Poly(alkyl cyanoacrylate) Nanoparticles in Mice and Effect on Tumor Infiltration of Macrophages into a Patient-Derived Breast Cancer Xenograft
por: Pandya, Abhilash D., et al.
Publicado: (2021)

Ceramide-containing liposomes with doxorubicin: time and cell-dependent effect of C6 and C12 ceramide
por: Øverbye, Anders, et al.
Publicado: (2017)

The expression of the long NEAT1_2 isoform is associated with human epidermal growth factor receptor 2-positive breast cancers
por: Knutsen, Erik, et al.
Publicado: (2020)

High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer
por: Normann, Lisa Svartdal, et al.
Publicado: (2023)

Protein Signature Predicts Response to Neoadjuvant Treatment With Chemotherapy and Bevacizumab in HER2-Negative Breast Cancers
por: Haugen, Mads H., et al.
Publicado: (2021)

hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma
por: Fleten, Karianne G, et al.
Publicado: (2016)

Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors
por: Seip, Kotryna, et al.
Publicado: (2016)

HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR
por: Ingthorsson, S, et al.
Publicado: (2016)

STAMP2 is required for human adipose-derived stem cell differentiation and adipocyte-facilitated prostate cancer growth in vivo
por: Lindstad, Torstein, et al.
Publicado: (2016)

Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population‐based series and a randomized phase III study on adjuvant chemotherapy
por: Boye, Kjetil, et al.
Publicado: (2016)

Targeting MCT-1 oncogene inhibits Shc pathway and xenograft tumorigenicity
por: Shih, Hung-Ju, et al.
Publicado: (2012)

Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H
por: Revheim, Mona-Elisabeth, et al.
Publicado: (2013)

Deciphering biological characteristics of tumorigenic subpopulations in human colorectal cancer reveals cellular plasticity
por: Mirzaei, Hamed, et al.
Publicado: (2016)

Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.
por: Maelandsmo, G. M., et al.
Publicado: (1996)

Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome
por: Aure, Miriam Ragle, et al.
Publicado: (2017)

AXL inhibition improves BRAF-targeted treatment in melanoma
por: Nyakas, Marta, et al.
Publicado: (2022)

Quantification of Tumor Hypoxia through Unsupervised Modelling of Consumption and Supply Hypoxia MR Imaging in Breast Cancer
por: Mo, Torgeir, et al.
Publicado: (2022)

Modeling luminal breast cancer heterogeneity: combination therapy to suppress a hormone receptor-negative, cytokeratin 5-positive subpopulation in luminal disease
por: Knox, Aaron J, et al.
Publicado: (2014)

Luminal enhancement in intracranial aneurysms: fact or feature?—A quantitative multimodal flow analysis
por: Gaidzik, Franziska, et al.
Publicado: (2021)

Sensitization of interferon-γ induced apoptosis in human osteosarcoma cells by extracellular S100A4
por: Pedersen, Kjetil Boye, et al.
Publicado: (2004)

Tumorigenic and Metastatic Role of CD44(−/low)/CD24(−/low) Cells in Luminal Breast Cancer
por: Vikram, Rajeev, et al.
Publicado: (2020)

Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial
por: Engebraaten, Olav, et al.
Publicado: (2012)

In vivo loss of tumorigenicity in a patient-derived orthotopic xenograft mouse model of ependymoma
por: Whitehouse, Jacqueline P., et al.
Publicado: (2023)

Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model
por: Kim, Eugene, et al.
Publicado: (2016)

Long-Term Suture Breakage After Scleral Fixation of a Modified Capsular Tension Ring with Polypropylene 10-0 Suture
por: Kristianslund, Olav, et al.
Publicado: (2021)

A combined experimental-computational approach uncovers a role for the Golgi matrix protein Giantin in breast cancer progression
por: Ghannoum, Salim, et al.
Publicado: (2023)

Recovery of cell subpopulations from human tumour xenografts following dissociation with different enzymes.
por: Allalunis-Turner, M. J., et al.
Publicado: (1986)

Ionizing radiation abrogates the pro-tumorigenic capacity of cancer-associated fibroblasts co-implanted in xenografts
por: Grinde, Maria Tunset, et al.
Publicado: (2017)

Different tumorigenicity and distinct metastasis and gene signature between orthotopic and subcutaneous neuroblastoma xenografted mice
por: Han, Rui, et al.
Publicado: (2022)

Interpretation of Multivariate Association Patterns between Multicollinear Physical Activity Accelerometry Data and Cardiometabolic Health in Children—A Tutorial
por: Aadland, Eivind, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dakle94f60u737rfececjgiur6